CSII Cardiovascular Systems Inc

Price (delayed)

$16.19

Market cap

$660.31M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.84

Enterprise value

$613.74M

Cardiovascular Systems, Inc., based in St. Paul, Minn., is a medical device company focused on developing and commercializing innovative solutions for treating vascular and coronary disease. The company's orbital atherectomy ...

Highlights
Cardiovascular Systems's revenue has increased by 6% YoY but it has decreased by 2.8% QoQ
CSII's net income is down by 40% YoY and by 13% from the previous quarter
The EPS has contracted by 31% YoY and by 14% from the previous quarter

Key stats

What are the main financial stats of CSII
Market
Shares outstanding
40.79M
Market cap
$660.31M
Enterprise value
$613.74M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
2.59
Price to sales (P/S)
2.6
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.51
Earnings
Revenue
$244.71M
EBIT
-$30.56M
EBITDA
-$25.56M
Free cash flow
-$17.32M
Per share
EPS
-$0.84
Free cash flow per share
-$0.44
Book value per share
$6.25
Revenue per share
$6.23
TBVPS
$7.84
Balance sheet
Total assets
$323.99M
Total liabilities
$70.49M
Debt
$20.39M
Equity
$253.5M
Working capital
$198.89M
Liquidity
Debt to equity
0.08
Current ratio
5.28
Quick ratio
4.45
Net debt/EBITDA
1.82
Margins
EBITDA margin
-10.4%
Gross margin
72.3%
Net margin
-13.3%
Operating margin
-12.8%
Efficiency
Return on assets
-9.7%
Return on equity
-12.4%
Return on invested capital
-13.6%
Return on capital employed
-11%
Return on sales
-12.5%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

CSII stock price

How has the Cardiovascular Systems stock price performed over time
Intraday
-3.17%
1 week
-0.55%
1 month
6.65%
1 year
-55.98%
YTD
-13.79%
QTD
12.74%

Financial performance

How have Cardiovascular Systems's revenue and profit performed over time
Revenue
$244.71M
Gross profit
$176.91M
Operating income
-$31.23M
Net income
-$32.53M
Gross margin
72.3%
Net margin
-13.3%
CSII's operating income is down by 44% year-on-year and by 15% since the previous quarter
CSII's net income is down by 40% YoY and by 13% from the previous quarter
CSII's operating margin is down by 36% year-on-year and by 19% since the previous quarter
The net margin has contracted by 32% YoY and by 16% from the previous quarter

Growth

What is Cardiovascular Systems's growth rate over time

Valuation

What is Cardiovascular Systems stock price valuation
P/E
N/A
P/B
2.59
P/S
2.6
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.51
The EPS has contracted by 31% YoY and by 14% from the previous quarter
CSII's P/B is 63% lower than its 5-year quarterly average of 7.2 and 40% lower than its last 4 quarters average of 4.5
CSII's equity is down by 6% year-on-year and by 2.3% since the previous quarter
The P/S is 48% less than the 5-year quarterly average of 5.2 and 40% less than the last 4 quarters average of 4.5
Cardiovascular Systems's revenue has increased by 6% YoY but it has decreased by 2.8% QoQ

Efficiency

How efficient is Cardiovascular Systems business performance
The company's return on equity fell by 44% YoY and by 14% QoQ
The ROA has decreased by 43% YoY and by 14% QoQ
The ROS has contracted by 36% YoY and by 17% from the previous quarter
Cardiovascular Systems's return on invested capital has decreased by 25% YoY and by 14% QoQ

Dividends

What is CSII's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for CSII.

Financial health

How did Cardiovascular Systems financials performed over time
CSII's quick ratio is down by 12% from the previous quarter and by 10% YoY
Cardiovascular Systems's current ratio has decreased by 11% QoQ and by 7% YoY
The debt is 92% less than the equity
CSII's equity is down by 6% year-on-year and by 2.3% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.